Germline RET Leu56Met Variant Is Likely Not Causative of Multiple Endocrine Neoplasia Type 2

Activating variants in the receptor tyrosine kinase REarranged during Transfection (RET) cause multiple endocrine neoplasia type 2 (MEN 2), an autosomal dominantly inherited cancer-susceptibility syndrome. The variant c.166C>A, p.Leu56Met in RET was recently reported in two patients with medu...

Full description

Saved in:
Bibliographic Details
Main Authors: Anna Reimer Hansen, Line Borgwardt, Åse Krogh Rasmussen, Christian Godballe, Morten Møller Poulsen, Filipe G. Vieira, Jes Sloth Mathiesen, Maria Rossing
Format: article
Language:EN
Published: Frontiers Media S.A. 2021
Subjects:
RET
Online Access:https://doaj.org/article/c8956c858a2e49a5a601b88ae41a02d3
Tags: Add Tag
No Tags, Be the first to tag this record!